G1 Therapeutics (GTHX) PT Raised to $41 at Raymond James, Following Discussion With Management Following Clinical Update

February 16, 2021 3:18 PM EST
Get Alerts GTHX Hot Sheet
Price: $22.46 -0.97%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 11 | New: 74
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Raymond James analyst Dane Leone raised the price target on G1 Therapeutics (NASDAQ: GTHX) to $41.00 (from $21.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Raymond James